Opsonization enhancement through antibody binding

Opsonization enhancement through antibody binding is not a single molecule or receptor but rather describes a biological process in which antibodies bind to antigens on the surface of pathogens. This "coating" marks the pathogen for destruction and facilitates its recognition and ingestion by phagocytic immune cells such as macrophages and neutrophils. The Fab region of an antibody binds to the antigen, while the Fc region interacts with Fc receptors on phagocytes, promoting efficient uptake and clearance of the target[1][2][3]. Complement proteins like C3b can also act as opsonins. This mechanism is central to adaptive immunity's ability to clear infections but is not itself a druggable molecular target—rather, it is exploited by therapeutic antibodies designed to enhance immune clearance of pathogens or abnormal cells. Note: The entry "Opsonization enhancement through antibody binding" refers to an immunological mechanism/process rather than a discrete protein, gene product, enzyme, transporter, or receptor. It should not be considered a canonical therapeutic target in structured databases focused on molecules/receptors[1][2][3].

Other names

OpsonizationAntibody-mediated opsonizationAntibody opsonizationEnhanced phagocytosis via antibodies

Enhancement of phagocytosis by marking pathogens with antibodies for recognition by immune cells[1][2][3]